Yanamandra U, Karunakaran P, Khadwal A, Prakash G, Lad D, Naseem S et al (2018) Invasive fungal infections in Acute promyelocytic leukemia on dual differentiating agents: Real World Data. Indian J Hematol Blood Transfus 34(3):466–468

Article  PubMed  Google Scholar 

Tallman MS, Andersen JW, Schiffer CA, Appelbaum FR, Feusner JH, Ogden A et al (2000) Clinical description of 44 patients with acute promyelocytic leukemia who developed the retinoic acid syndrome. Blood 95(1):90–95

CAS  PubMed  Google Scholar 

Singh C, Yanamandra U, Karunakaran P, Jindal N, Kumar SR, Saini N et al (2023) Long-term real-world outcomes of patients with acute promyelocytic leukaemia treated with arsenic trioxide and all-trans retinoic acid without chemotherapy—a retrospective, single-centre study. Br J Haematol 201(2):249–255

Article  CAS  PubMed  Google Scholar 

Singh C, Wadhera S, Yanamandra U, Karunakaran P, Jindal N, Kumar SR et al (2022) High-dose hydroxyurea with differentiating agents for treating ultra-high-risk acute promyelocytic leukemia in resource-challenged settings. Acta Oncol 61(12):1512–1514

Article  CAS  PubMed  Google Scholar 

Pagano L, Stamouli M, Tumbarello M, Verga L, Candoni A, Cattaneo C et al (2015) Risk of invasive fungal infection in patients affected by acute promyelocytic leukaemia. A report by the SEIFEM-D registry. Br J Haematol 170(3):434–439

Article  PubMed  Google Scholar 

Kapoor J, Mirgh SP, Agrawal N, Khushoo V, Tejwani N, Singh R et al (2022) High risk Acute promyelocytic leukemia - an Enigma for hematologists: optimizing treatment with APML-4 protocol. Indian J Hematol Blood Transfus 38(2):394–402

Article  PubMed  Google Scholar 

Ghavamzadeh A, Alimoghaddam K, Rostami S, Ghaffari SH, Jahani M, Iravani M et al (2011) Phase II study of single-Agent Arsenic Trioxide for the front-line therapy of Acute promyelocytic leukemia. J Clin Oncol 29(20):2753–2757

Article  CAS  PubMed  Google Scholar 

Kulkarni UP, Selvarajan S, Lionel S, Prakash MA, Palani HK, Balasundaram N et al (2022) Real world data with concurrent retinoic acid and arsenic trioxide for the treatment of acute promyelocytic leukemia. Blood Cancer J 12(1):22

Article  PubMed  PubMed Central  Google Scholar 

Silva WFD Jr., Rosa LID, Marquez GL, Bassolli L, Tucunduva L, Silveira DRA et al (2019) Real-life outcomes on Acute promyelocytic leukemia in Brazil - Early deaths are still a Problem. Clin Lymphoma Myeloma Leuk 19(2):e116–e22

Article  PubMed  Google Scholar